Intra-Cellular Therapies (STU:23I) Inventories, Finished Goods : €0.0 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Intra-Cellular Therapies Inventories, Finished Goods?

Intra-Cellular Therapies's quarterly finished goods increased from Mar. 2024 (€6.5 Mil) to Jun. 2024 (€7.4 Mil) but then declined from Jun. 2024 (€7.4 Mil) to Sep. 2024 (€0.0 Mil).

Intra-Cellular Therapies's annual finished goods increased from Dec. 2021 (€2.7 Mil) to Dec. 2022 (€3.9 Mil) and increased from Dec. 2022 (€3.9 Mil) to Dec. 2023 (€6.8 Mil).

Intra-Cellular Therapies Inventories, Finished Goods Historical Data

The historical data trend for Intra-Cellular Therapies's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intra-Cellular Therapies Inventories, Finished Goods Chart

Intra-Cellular Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

2.29

2.71

3.87

6.76

Intra-Cellular Therapies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Inventories, Finished Goods	Get a 7-Day Free Trial															4.72	6.76	6.51	7.37	-

Intra-Cellular Therapies Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Intra-Cellular Therapies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (STU:23I) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

ITCI:USA ITCI:Mexico I2TC34:Brazil

Address

430 East 29th Street, New York, NY, USA, 10016

Website

https://www.intracellulartherapies.com

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies Headlines

No Headlines